Does sugammadex (cyclohexanol derivative) affect the effectiveness of an intrauterine device (IUD) in patients undergoing a procedure with neuromuscular blockade reversal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sugammadex Does Not Affect IUD Effectiveness

Sugammadex can be safely used in patients with IUDs without concern for contraceptive failure, but patients taking oral hormonal contraceptives must follow "missed pill rules" after sugammadex administration. 1

Key Clinical Distinction

The critical issue with sugammadex is its interaction with oral hormonal contraceptives, not intrauterine devices:

  • IUDs are not affected by sugammadex because they work through local mechanisms (copper toxicity to sperm or local progestin effects) rather than systemic hormonal pathways 1

  • Oral contraceptives ARE affected because sugammadex can bind to progestins in the circulation, potentially reducing their effectiveness 1

Practical Management

For Patients with IUDs:

  • No special precautions are needed - proceed with sugammadex at standard doses based on depth of neuromuscular blockade 1, 2
  • No backup contraception is required 1
  • Standard dosing applies: 2 mg/kg for moderate blockade or 4 mg/kg for deep blockade 2

For Patients on Oral Contraceptives:

  • Counsel patients to follow "missed pill rules" after sugammadex administration 1
  • This typically means using backup contraception for 7 days 1
  • Document this counseling in the medical record 1

Mechanism Explanation

Sugammadex is a modified gamma-cyclodextrin that encapsulates steroidal neuromuscular blocking agents (rocuronium and vecuronium) 1. While it can also bind to steroid hormones like progestins found in oral contraceptives, this interaction does not affect IUDs because:

  • IUDs release hormones locally in the uterus (hormonal IUDs) or work through non-hormonal mechanisms (copper IUDs) 1
  • The systemic hormone levels from IUDs are minimal compared to oral contraceptives 1
  • Sugammadex's large molecular size and high polarity limit its distribution 1

Common Pitfall to Avoid

Do not confuse IUDs with oral contraceptives when counseling patients about sugammadex. The guideline specifically states that the contraceptive interaction warning applies to "oral hormonal contraceptives," not all forms of contraception 1. Unnecessarily alarming patients with IUDs or recommending backup contraception when it's not needed can cause undue anxiety and confusion.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Reversal of General Anesthesia Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.